Eating Disorders — Eating Disorders and Autism Spectrum Disorders
Citation(s)
Atienza, F , Moreno, Y., & Balaguer, I. (2000). Escala de autoestima de Rosenberg. Recuperado de: https://www. uv. es/uipd/cuestionarios/accesolibre/EAR.
Beck, A T., Steer, R. A., & Brown, G. K. (1996). BDI-II: Beck depression inventory. Pearson.
Cooper, P J., Taylor, M. J., Cooper, Z., & Fairbum, C. G. (1987). The development and validation of the Body Shape Questionnaire. International Journal of eating disorders, 6(4), 485-494.
Huke V, Turk J, Saeidi S, Kent A, Morgan JF Autism spectrum disorders in eating disorder populations: a systematic review. Eur Eat Disord Rev. 2013 Sep;21(5):345-51. doi: 10.1002/erv.2244. Epub 2013 Jul 31.
Khalsa SS, Portnoff LC, McCurdy-McKinnon D, Feusner JD What happens after treatment? A systematic review of relapse, remission, and recovery in anorexia nervosa. J Eat Disord. 2017 Jun 14;5:20. doi: 10.1186/s40337-017-0145-3. eCollection 2017.
Nielsen S, Anckarsater H, Gillberg C, Gillberg C, Rastam M, Wentz E Effects of autism spectrum disorders on outcome in teenage-onset anorexia nervosa evaluated by the Morgan-Russell outcome assessment schedule: a controlled community-based study. Mol Autism. 2015 Mar 8;6:14. doi: 10.1186/s13229-015-0013-4. eCollection 2015.
Spielberger, C D., Gorsuch, R. L., Lushene, R. E., Vagg, P. R., & Jacobs, G. A. (1970). Manual for the state-trait inventory. Consulting Psychologists, Palo Alto, California.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
